Metformin Ameliorates Inflammation and Airway Remodeling of Experimental Allergic Asthma in Mice by Restoring AMPKα Activity

Metformin has been involved in modulating inflammatory state and inhibiting cell proliferation and angiogenesis. This study aimed to determine whether metformin alleviates airway inflammation and remodeling of experimental allergic asthma and elucidate the underlying mechanism. We sensitized and cha...

Full description

Bibliographic Details
Main Authors: Wenxian Ma, Qiaoyan Jin, Haiqin Guo, Xinpeng Han, Lingbin Xu, Shemin Lu, Changgui Wu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-01-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.780148/full
_version_ 1818022404132175872
author Wenxian Ma
Wenxian Ma
Qiaoyan Jin
Haiqin Guo
Xinpeng Han
Lingbin Xu
Shemin Lu
Changgui Wu
author_facet Wenxian Ma
Wenxian Ma
Qiaoyan Jin
Haiqin Guo
Xinpeng Han
Lingbin Xu
Shemin Lu
Changgui Wu
author_sort Wenxian Ma
collection DOAJ
description Metformin has been involved in modulating inflammatory state and inhibiting cell proliferation and angiogenesis. This study aimed to determine whether metformin alleviates airway inflammation and remodeling of experimental allergic asthma and elucidate the underlying mechanism. We sensitized and challenged mice with ovalbumin (OVA) to induce allergic asthma. During the challenge period, metformin was administered by intraperitoneal injection. By histopathological and immunohistochemical analyses, metformin-treated mice showed a significant alleviation in airway inflammation, and in the parameters of airway remodeling including goblet cell hyperplasia, collagen deposition and airway smooth muscle hypertrophy compared to those in the OVA-challenged mice. We also observed elevated levels of multiple cytokines (IL-4, IL-5, IL-13, TNF-α, TGF-β1 and MMP-9) in the bronchoalveolar lavage fluid, OVA-specific IgE in the serum and angiogenesis-related factors (VEGF, SDF-1 and CXCR4) in the plasma from asthmatic mice, while metformin reduced all these parameters. Additionally, the activity of 5′-adenosine monophosphate-activated protein kinase a (AMPKα) in the lungs from OVA-challenged mice was remarkably lower than control ones, while after metformin treatment, the ratio of p-AMPKα to AMPKα was upregulated and new blood vessels in the sub-epithelial area as evidenced by CD31 staining were effectively suppressed. These results indicate that metformin ameliorates airway inflammation and remodeling in an OVA-induced chronic asthmatic model and its protective role could be associated with the restoration of AMPKα activity and decreased asthma-related angiogenesis.
first_indexed 2024-04-14T08:30:55Z
format Article
id doaj.art-4055f5d36dd1446991b49e0f28a9bb3e
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-04-14T08:30:55Z
publishDate 2022-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-4055f5d36dd1446991b49e0f28a9bb3e2022-12-22T02:03:54ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122022-01-011310.3389/fphar.2022.780148780148Metformin Ameliorates Inflammation and Airway Remodeling of Experimental Allergic Asthma in Mice by Restoring AMPKα ActivityWenxian Ma0Wenxian Ma1Qiaoyan Jin2Haiqin Guo3Xinpeng Han4Lingbin Xu5Shemin Lu6Changgui Wu7Department of Pulmonary and Critical Care Medicine, Xijing Hospital, Fourth Military Medical University, Xi’an, ChinaDepartment of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Xi’an Jiaotong University Health Science Center, Xi’an, ChinaDepartment of Pediatrics, The Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an, ChinaDepartment of Pulmonary and Critical Care Medicine, Third Military Medical University Southwest Hospital, Chongqing, ChinaDepartment of Pulmonary and Critical Care Medicine, Xi’an International Medical Center Hospital, Xi’an, ChinaDepartment of Pulmonary and Critical Care Medicine, Shaanxi Provincial People’s Hospital, Xi’an, ChinaDepartment of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Xi’an Jiaotong University Health Science Center, Xi’an, ChinaDepartment of Pulmonary and Critical Care Medicine, Xi’an International Medical Center Hospital, Xi’an, ChinaMetformin has been involved in modulating inflammatory state and inhibiting cell proliferation and angiogenesis. This study aimed to determine whether metformin alleviates airway inflammation and remodeling of experimental allergic asthma and elucidate the underlying mechanism. We sensitized and challenged mice with ovalbumin (OVA) to induce allergic asthma. During the challenge period, metformin was administered by intraperitoneal injection. By histopathological and immunohistochemical analyses, metformin-treated mice showed a significant alleviation in airway inflammation, and in the parameters of airway remodeling including goblet cell hyperplasia, collagen deposition and airway smooth muscle hypertrophy compared to those in the OVA-challenged mice. We also observed elevated levels of multiple cytokines (IL-4, IL-5, IL-13, TNF-α, TGF-β1 and MMP-9) in the bronchoalveolar lavage fluid, OVA-specific IgE in the serum and angiogenesis-related factors (VEGF, SDF-1 and CXCR4) in the plasma from asthmatic mice, while metformin reduced all these parameters. Additionally, the activity of 5′-adenosine monophosphate-activated protein kinase a (AMPKα) in the lungs from OVA-challenged mice was remarkably lower than control ones, while after metformin treatment, the ratio of p-AMPKα to AMPKα was upregulated and new blood vessels in the sub-epithelial area as evidenced by CD31 staining were effectively suppressed. These results indicate that metformin ameliorates airway inflammation and remodeling in an OVA-induced chronic asthmatic model and its protective role could be associated with the restoration of AMPKα activity and decreased asthma-related angiogenesis.https://www.frontiersin.org/articles/10.3389/fphar.2022.780148/fullasthmaairway inflammationairway remodelingmetforminAMPK
spellingShingle Wenxian Ma
Wenxian Ma
Qiaoyan Jin
Haiqin Guo
Xinpeng Han
Lingbin Xu
Shemin Lu
Changgui Wu
Metformin Ameliorates Inflammation and Airway Remodeling of Experimental Allergic Asthma in Mice by Restoring AMPKα Activity
Frontiers in Pharmacology
asthma
airway inflammation
airway remodeling
metformin
AMPK
title Metformin Ameliorates Inflammation and Airway Remodeling of Experimental Allergic Asthma in Mice by Restoring AMPKα Activity
title_full Metformin Ameliorates Inflammation and Airway Remodeling of Experimental Allergic Asthma in Mice by Restoring AMPKα Activity
title_fullStr Metformin Ameliorates Inflammation and Airway Remodeling of Experimental Allergic Asthma in Mice by Restoring AMPKα Activity
title_full_unstemmed Metformin Ameliorates Inflammation and Airway Remodeling of Experimental Allergic Asthma in Mice by Restoring AMPKα Activity
title_short Metformin Ameliorates Inflammation and Airway Remodeling of Experimental Allergic Asthma in Mice by Restoring AMPKα Activity
title_sort metformin ameliorates inflammation and airway remodeling of experimental allergic asthma in mice by restoring ampkα activity
topic asthma
airway inflammation
airway remodeling
metformin
AMPK
url https://www.frontiersin.org/articles/10.3389/fphar.2022.780148/full
work_keys_str_mv AT wenxianma metforminamelioratesinflammationandairwayremodelingofexperimentalallergicasthmainmicebyrestoringampkaactivity
AT wenxianma metforminamelioratesinflammationandairwayremodelingofexperimentalallergicasthmainmicebyrestoringampkaactivity
AT qiaoyanjin metforminamelioratesinflammationandairwayremodelingofexperimentalallergicasthmainmicebyrestoringampkaactivity
AT haiqinguo metforminamelioratesinflammationandairwayremodelingofexperimentalallergicasthmainmicebyrestoringampkaactivity
AT xinpenghan metforminamelioratesinflammationandairwayremodelingofexperimentalallergicasthmainmicebyrestoringampkaactivity
AT lingbinxu metforminamelioratesinflammationandairwayremodelingofexperimentalallergicasthmainmicebyrestoringampkaactivity
AT sheminlu metforminamelioratesinflammationandairwayremodelingofexperimentalallergicasthmainmicebyrestoringampkaactivity
AT changguiwu metforminamelioratesinflammationandairwayremodelingofexperimentalallergicasthmainmicebyrestoringampkaactivity